Cargando…

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement

BACKGROUND: The European Respiratory Society recently published an important statement reviewing available evidence on diagnosis and treatment of lung disease associated to alpha-1 antitrypsin deficiency (AATD). Several issues on this topic still remain unresolved and subject of interpretation accor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gramegna, Andrea, Aliberti, Stefano, Confalonieri, Marco, Corsico, Angelo, Richeldi, Luca, Vancheri, Carlo, Blasi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174569/ https://www.ncbi.nlm.nih.gov/pubmed/30338069 http://dx.doi.org/10.1186/s40248-018-0153-4

Ejemplares similares

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement
por: Blasi, Francesco, et al.
Publicado: (2021)

Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency
por: Yeung, Ho-Man, et al.
Publicado: (2022)

CELA1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency
por: Devine, Andrew J., et al.
Publicado: (2023)

Identifying Alpha-1 Antitrypsin Deficiency Based on Computed Tomography Evidence of Emphysema
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
por: Perotin, Jeanne Marie, et al.
Publicado: (2018)

European Respiratory Society statement on long COVID follow-up
por: Antoniou, Katerina M., et al.
Publicado: (2022)

The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement
por: Blanc, Paul D., et al.
Publicado: (2019)

Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema
por: Blanco, Ignacio, et al.
Publicado: (2011)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency
por: Everaerts, Stephanie, et al.
Publicado: (2023)

Syndrome of Combined Pulmonary Fibrosis and Emphysema: An official research statement from American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Asociación Latinoamericana de Tórax (ALAT)
por: Cottin, Vincent, et al.
Publicado: (2022)

Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency
por: María Hernández Pérez, José, et al.
Publicado: (2022)

The best of respiratory infections from the 2015 European Respiratory Society International Congress
por: Polverino, Eva, et al.
Publicado: (2016)

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; Methodological advances
por: Parr, David G, et al.
Publicado: (2008)

Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD)
por: Ataya, Ali
Publicado: (2020)

Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
por: Zhumagaliyeva, Ardak, et al.
Publicado: (2017)

Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018)

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
por: Celli, Bartolome R., et al.
Publicado: (2015)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency
por: Barzon, Valentina, et al.
Publicado: (2022)

Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
por: O'Brien, Michael E, et al.
Publicado: (2020)

Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease
por: Serban, K.A., et al.
Publicado: (2022)

Molecular diagnosis of alpha1‐antitrypsin deficiency: A new method based on Luminex technology
por: Ottaviani, Stefania, et al.
Publicado: (2020)

Treatable Traits in Chronic Respiratory Disease: A Comprehensive Review
por: Lee, Yong Qin, et al.
Publicado: (2021)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
por: Dunlea, Danielle M, et al.
Publicado: (2018)

A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma
por: Theegarten, Dirk, et al.
Publicado: (2004)

In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice
por: Sutter, Marco A., et al.
Publicado: (2020)

Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema
por: Takeda, Katsuyuki, et al.
Publicado: (2021)

Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice
por: Park, Sangmi S., et al.
Publicado: (2023)

Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration
por: Bari, Elia, et al.
Publicado: (2019)

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
por: Graham, Brian L., et al.
Publicado: (2019)

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale
por: Ferrarotti, I., et al.
Publicado: (2021)

Clinical applications of azithromycin microspheres in respiratory tract infections
por: Blasi, Francesco, et al.
Publicado: (2007)

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
por: Stolk, Jan, et al.
Publicado: (2005)

Identification of a rare p.G320R alpha-1-antitrypsin variant in emphysema and lung cancer patients
por: Ljujic, Mila, et al.
Publicado: (2010)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
por: Viglio, Simona, et al.
Publicado: (2021)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k7bhshek1k9t7hsicpbq0rmsms